cas 2088458-39-1|| where to buy tert-butyl 5-oxo-1H-pyrazole-2-carboxylate

Nombre del producto:tert-butyl 5-oxo-1H-pyrazole-2-carboxylate

IUPAC Name:tert-butyl 3-oxo-2,3-dihydro-1H-pyrazole-1-carboxylate

Unidad de embalaje	Stock disponible	Precio($)
CM330037-250mg	in stock	Ǝũ
CM330037-1g	in stock	ŵǜư
CM330037-5g	in stock	ǜȺǊ
CM330037-10g	in stock	ǊũȺ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2088458-39-1 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2088458-39-1; Fórmula molecular:C8H12N2O3; Punto de fusión:-; Código de sonrisas:O=C(N(C=C1)NC1=O)OC(C)(C)C; Densidad:

: Número de catálogo:CM330037; Peso molecular:184.19; Punto de ebullición:; Nº Mdl:MFCD31742743; Almacenamiento:

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Vanzacaftor; Vertex Pharmaceuticals announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor is also undergoing regulatory review in multiple other jurisdictions, including by the Food and Drug Administration (FDA) in the U.S. and by the European Medicines Agency (EMA) in the E.U.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.